Ambev S.A. [NYSE: ABEV] stock went on a downward path that fall over -1.36% on Friday, amounting to a one-week price decrease of less than -3.64%. The company report on March 18, 2022 that Ambev’s 2021 Annual Report on Form 20-F Available on Our Website.
Ambev S.A. [B3: ABEV3; NYSE: ABEV] announces that the Company’s annual report on Form 20-F for the year ended December 31, 2021 was filed with the U.S. Securities and Exchange Commission – SEC (www.sec.gov) on March 18, 2022 and is available on the Company’s website (ri.ambev.com.br) and also on the Company’s page on SEC’s database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company’s complete audited financial statements contained in the Form 20-F free of charge, upon request.
To access the full document, please access the following link: click here.
Over the last 12 months, ABEV stock rose by 7.87%. The one-year Ambev S.A. stock forecast points to a potential upside of 16.38. The average equity rating for ABEV stock is currently 2.90, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $45.80 billion, with 15.74 billion shares outstanding and 4.40 billion shares in the current float. Compared to the average trading volume of 23.79M shares, ABEV stock reached a trading volume of 30361321 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Ambev S.A. [ABEV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABEV shares is $3.48 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABEV stock is a recommendation set at 2.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Ambev S.A. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 03, 2021. While these analysts kept the previous recommendation, Barclays dropped their target price from $4 to $3.50. The new note on the price target was released on October 06, 2021, representing the official price target for Ambev S.A. stock. Previously, the target price had yet another raise to $2.60, while Goldman analysts kept a Sell rating on ABEV stock.
The Average True Range (ATR) for Ambev S.A. is set at 0.09, with the Price to Sales ratio for ABEV stock in the period of the last 12 months amounting to 0.63. The Price to Book ratio for the last quarter was 0.55.
ABEV Stock Performance Analysis:
Ambev S.A. [ABEV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.64. With this latest performance, ABEV shares dropped by -7.32% in over the last four-week period, additionally plugging by 2.00% over the last 6 months – not to mention a rise of 7.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ABEV stock in for the last two-week period is set at 41.15, with the RSI for the last a single of trading hit 34.65, and the three-weeks RSI is set at 45.21 for Ambev S.A. [ABEV]. The present Moving Average for the last 50 days of trading for this stock 2.96, while it was recorded at 2.95 for the last single week of trading, and 2.94 for the last 200 days.
ABEV Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABEV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Ambev S.A. go to 9.60%.
Ambev S.A. [ABEV] Insider Position Details
130 institutional holders increased their position in Ambev S.A. [NYSE:ABEV] by around 88,996,566 shares. Additionally, 132 investors decreased positions by around 114,534,920 shares, while 55 investors held positions by with 1,129,578,537 shares. The mentioned changes placed institutional holdings at 1,333,110,023 shares, according to the latest SEC report filing. ABEV stock had 49 new institutional investments in for a total of 11,229,396 shares, while 33 institutional investors sold positions of 9,844,482 shares during the same period.